A research team has made a breakthrough in epigenetic drug discovery. The researchers have successfully developed a ...
Many cancers harbor pro-proliferative mutations of the mitogen-activated protein kinase (MAPK) pathway. In BRAF-driven melanoma cells treated with BRAF inhibitors, subpopulations of cells escape ...
Researchers developed LS-170, an inhibitor of the ATAC complex, which suppressed oncogene expression and reduced tumor growth ...
Harvard Medical School researchers have uncovered crucial insights into how an emerging class of antiviral drugs works.
The human genome has to be carefully organized so it will fit inside of the nuclei of cells, while also remaining accessible ...
Andrés Aguilera's laboratory, in collaboration with that of Ralf Wellinger (both professors in the Department of Genetics at the University of Seville in CABIMER) and with PharmaMAR, has identified ...
Members of a new class of antivirals are being tested in U.S. clinical trials, and one has gained approval in Japan, but how ...
DNA doesn’t just sit still inside our cells — it folds, loops, and rearranges in ways that shape how genes behave.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback